Banjac Katarina, Obradovic Milan, Zafirovic Sonja, Isenovic Esma R
Department of Radiobiology and Molecular Genetics, "VINČA" Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.
Arch Med Sci. 2024 Jan 12;20(3):1011-1015. doi: 10.5114/aoms/177618. eCollection 2024.
Insulin-like growth factor-1 (IGF-1) promotes survival and inhibits cardiac autophagy disruption.
Male Wistar rats were treated with IGF-1 (50 µg/kg), and 24 h after injection hearts were excised. The level of interaction between Beclin-1 and the α subunit of sodium/potassium-adenosine triphosphates (Na/K-ATPase), and phosphorylated forms of IGF-1 receptor/insulin receptor (IGF-1R/IR), forkhead box protein O1 (FOXO1) and AMP-activated protein kinase (AMPK) were measured.
The results indicate that IGF-1 decreased Beclin-1's association with Na/K-ATPase ( < 0.05), increased IGF-1R/IR and FOXO1 phosphorylation ( < 0.05), and decreased AMPK phosphorylation ( < 0.01) in rats' hearts.
The new IGF-1 therapy may control autosis and minimize cardiomyocyte mortality.
胰岛素样生长因子-1(IGF-1)可促进存活并抑制心脏自噬破坏。
用IGF-1(50μg/kg)处理雄性Wistar大鼠,注射后24小时取出心脏。检测Beclin-1与钠/钾-三磷酸腺苷酶(Na/K-ATPase)α亚基之间的相互作用水平,以及IGF-1受体/胰岛素受体(IGF-1R/IR)、叉头框蛋白O1(FOXO1)和AMP活化蛋白激酶(AMPK)的磷酸化形式。
结果表明,IGF-1降低了大鼠心脏中Beclin-1与Na/K-ATPase的结合(<0.05),增加了IGF-1R/IR和FOXO1的磷酸化(<0.05),并降低了AMPK的磷酸化(<0.01)。
新的IGF-1疗法可能控制自噬并使心肌细胞死亡率降至最低。